| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/05/2003 | EP1280802A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 02/05/2003 | EP1280799A1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 02/05/2003 | EP1280798A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 02/05/2003 | EP1280789A1 Cdk inhibitors having 3-hydroxychromen-4-one structure |
| 02/05/2003 | EP1280776A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 02/05/2003 | EP1280774A1 Substituted indoles as parp inhibitors |
| 02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
| 02/05/2003 | EP1280757A2 New gamma selective retinoids |
| 02/05/2003 | EP1280556A1 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 02/05/2003 | EP1280553A2 Methods of affecting laminin 5 processing |
| 02/05/2003 | EP1280552A2 Compositions and methods of treating cancer using compositions comprising an inhibitor of endothelin receptor activity |
| 02/05/2003 | EP1280546A1 Method and composition for the treatment of angiogenesis |
| 02/05/2003 | EP1280537A2 Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof |
| 02/05/2003 | EP1280527A2 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 02/05/2003 | EP1280524A2 Methods and compositions for modulating alpha adrenergic receptor activity |
| 02/05/2003 | EP1280518A2 Liposome drug delivery |
| 02/05/2003 | EP1280517A1 Beta-glucans encapsulated in liposomes |
| 02/05/2003 | EP1280515A2 Pharmaceutical compositions comprising cannabis |
| 02/05/2003 | EP1280409A1 A gene therapy system and method using alpha-msh and its derivatives |
| 02/05/2003 | EP1200101A4 Methods for transdifferentiation of body tissues |
| 02/05/2003 | EP1117653B1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 02/05/2003 | EP1037868B1 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
| 02/05/2003 | EP0934277B1 Process for the preparation of n- 2-(dimethylamino)ethyl]acridine-4-carboxamide |
| 02/05/2003 | EP0932391B1 Fusogenic liposome composition and method |
| 02/05/2003 | EP0817632B1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/05/2003 | EP0804231B1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 02/05/2003 | EP0794787B1 Compositions for the treatment of parasitic and fungal infections |
| 02/05/2003 | EP0745087B1 Novel cytotoxic macrolides, their isolation from a marine sponge and their use as antitumor agents |
| 02/05/2003 | EP0574512B1 Redirection of cellular immunity by receptor chimeras |
| 02/05/2003 | CN1395578A Byrido [2,3-d] pyrimidine-2, 7-diamine kinase inhibitors |
| 02/05/2003 | CN1395577A Ethanol solvate of (-)-cis-2-2(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-1methyl) piperidinyl]-4H-1-benzopyran-4-one |
| 02/05/2003 | CN1395576A Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one |
| 02/05/2003 | CN1395574A Food product and producing method |
| 02/05/2003 | CN1395573A Extraction of flavonoids |
| 02/05/2003 | CN1395571A Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395558A Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 02/05/2003 | CN1395490A Antigen-specific IgE antibody production inhibitors |
| 02/05/2003 | CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 02/05/2003 | CN1394956A Human epidermal growth factor receptor specific fusion protein and its application |
| 02/05/2003 | CN1394954A Fusion protein with function of resisting tumor and its application |
| 02/05/2003 | CN1394874A Human thio-oxidizing proteinoid gene and three-D space structure of its coded protein and physiologic function |
| 02/05/2003 | CN1394873A Human calcium ion/calmodulin dependent protein kinase II inhibitory protein and its application |
| 02/05/2003 | CN1394867A Medicinal oligose and its preparation method and medicine composition containing said oligose |
| 02/05/2003 | CN1394857A Compound used as antiproliferative agent and glycinamide ribonucleotide transformylase inhibitor |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/05/2003 | CN1394646A Anticancer Chinese medicine powder preparation and its preparation method |
| 02/05/2003 | CN1394645A Anticancer dietary medicine composition and its preparation method |
| 02/05/2003 | CN1394644A Shenhong capsule with actions of removing blood stasis and obstruction |
| 02/05/2003 | CN1394637A Powder preparation for stopping pain and dispersing swelling |
| 02/05/2003 | CN1394616A Ziling tablet for curing carcinomatosis |
| 02/05/2003 | CN1394611A Arsenic trioxide (ATO) oral slow-releasing granules and its preparation method |
| 02/05/2003 | CN1394601A Joint chemical therapy method |
| 02/05/2003 | CN1394597A Process for preparing powder preparation |
| 02/05/2003 | CN1100778C Pyrrolopyriidines and processes for preapring thereof |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/05/2003 | CN1100771C Phosphononooxymethyl ethers for taxame derivatives |
| 02/05/2003 | CN1100770C Hydrolysis-promoitng taxane hydrophobic derivatives |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/05/2003 | CN1100569C Method for preparing tumour vaccinum |
| 02/05/2003 | CN1100567C Health-care enzymatic chitosan food |
| 02/05/2003 | CN1100566C Medicinal composition containing calcineurin phosphatase B subunit |
| 02/05/2003 | CN1100561C Apoptosis inducers |
| 02/05/2003 | CN1100555C Medicine for treating cancer |
| 02/05/2003 | CN1100550C Chinese medicine composition for curing various cancers |
| 02/05/2003 | CN1100544C Mercury chloride injection |
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/04/2003 | US6515173 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/04/2003 | US6515105 Vascular Endothelial Growth Factor binding to extracellular domain of NP-1 (Neuropilin-1); bioactive complexes; mediate useful cell responses or antagonize undesired biological activities; angiogenesis; cell differentiation |
| 02/04/2003 | US6515021 The compounds according to the invention have pronounced activity in the fields of cell differentiation and cell proliferation |
| 02/04/2003 | US6515016 Treating or preventing multiple sclerosis, by administering an antimicrotubule agent; treating various other inflammatory diseases |
| 02/04/2003 | US6515004 Useful in the treatment of Alzheimer's disease, chemotherapy-induced alopecia, and cardiovascular disease |
| 02/04/2003 | US6515003 Useful in the treatment of diseases related to lipid and carbohydrate metabolism |
| 02/04/2003 | US6514985 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/04/2003 | US6514983 Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase |
| 02/04/2003 | US6514974 Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity |
| 02/04/2003 | US6514972 Heteropolycyclic inhibitors of protein kinases |
| 02/04/2003 | US6514964 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors |
| 02/04/2003 | US6514960 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 02/04/2003 | US6514956 For treating diseases associated with progestogen dependence and for fertility control, abortion or contraception and for anticancer use |
| 02/04/2003 | US6514952 For the treatment and prophylaxis of diseases which are caused by an undesired extent of leucocyte adhesion and/or leucocyte migration such as rheumatoid arthritis or allergic disorders |
| 02/04/2003 | US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 02/04/2003 | US6514745 Oncoprotein protein kinase |
| 02/04/2003 | US6514738 Given amino acid sequence; microtubular depolymerization activity in presence of ATP; can be used in diagnosis and treatment of cancer, neurological and vesicular transport disorders. |
| 02/04/2003 | US6514729 Recombinant interferon-beta muteins |
| 02/04/2003 | US6514712 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 02/04/2003 | US6514711 Which forms a reconstructed epidermis, used to test various factors on human skin equivalent, such as drugs, cosmetics, surfactants and detergents |
| 02/04/2003 | US6514696 Detection thereof; Using polynucleotide that hybridizes to given nucleotide sequence; Cancer |
| 02/04/2003 | US6514685 Detection of cancer using antibodies to the alphafeto protein receptor |
| 02/04/2003 | US6514535 For drug delivery |
| 02/04/2003 | US6514519 1-octadecyl-2-methyl-sn-glycero-3-phosphocholine; oral administration |
| 02/04/2003 | US6514499 Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof |
| 02/04/2003 | US6514497 Inhibition of LERK-2-mediated cell adhesion |
| 02/04/2003 | US6514494 Bacterial strain, processed plant extracts, compostions containing same, processes for their preparation and their therapeutic and industrial applications |
| 02/04/2003 | US6514491 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 02/04/2003 | CA2271478C Tissue specific expression of retinoblastoma protein |
| 02/04/2003 | CA2169019C Improvements in platinum complexes |
| 02/04/2003 | CA2122612C Pharmaceutical products for curing tumourous diseases and process for preparing same |
| 02/04/2003 | CA2112818C Mono and bis alkylamino-anthracyclines |